New patient guidelines for heart devices
April 17, 2011 in Medical researchA series of new guidelines for cardiac specialists has been developed to determine when heart failure patients should receive a mechanical heart-pumping device.
"The new guidelines will likely affect who is referred for a mechanical circulatory support device, and how early in the process a physician would consider implanting a left ventricular assist device," says Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory Support at Henry Ford Hospital. "These guidelines have the ability to change clinical practice patterns for patients with advanced heart failure."
Dr. Morgan will present the guidelines Saturday, April 16 at the International Society of Heart and Lung Transplantation (ISHLT) annual meeting in San Diego.
The left ventricular assist device (LVAD) is a battery-operated pumping device, surgically implanted to help a weakened heart pump blood.
Last year, approximately 2500 LVADs were implanted nationally, which is used chiefly for patients waiting for a heart transplant due to the chronic donor shortage. In other cases, it is used for long-term support in patients who are not eligible for a heart transplant.
Dr. Morgan played a leadership role in the formation of the ISHLT's Mechanical Circulatory Support Council that authored the guidelines, due to the high-quality, high-volume LVAD implant program at Henry Ford. The program has a growing national reputation in clinical, academic and research areas.
Provided by
Henry Ford Health System
-
Non-cardiac surgery: Safe for patients with heart device
Apr 15, 2011 |
not rated yet |
0
-
Study: Fewer infections with new heart-pump implant
May 27, 2010 |
not rated yet |
0
-
Long-lasting mechanical heart implanted for the first time in Canada in heart-failure patient
Oct 12, 2010 |
not rated yet |
0
-
Study examines earlier use of heart pumps in growing group of heart failure patients
Jan 24, 2011 |
not rated yet |
0
-
Newer heart devices significantly improve survival, complication rate and quality of life
Nov 17, 2009 |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
Your brain on dye: Imaging neuronal voltage with fluorescent sensors and molecular wires
Feb 24, 2012 |
4.9 / 5 (9) |
0
-
A couple of questions about schizophrenia
May 17, 2012
-
Paralyzed woman uses thoughts to move robotic arm
May 17, 2012
-
Coffee Decreases Risk of Death
May 17, 2012
-
Understanding the mechanisms of disease .
May 14, 2012
-
Short burst of hypersensitivity disorder?
May 13, 2012
-
Copper aspirinate
May 12, 2012
- More from Physics Forums - Medical Sciences
More news stories
Stopping cell migration may help block fibrosis and the spread of cancer
(Medical Xpress) -- Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling ...
Medical research
1 hour ago |
5 / 5 (1) |
0
|
Hitting parasites where they hurt: New research shows promise in the fight against Toxoplasmosis
Toxoplasmosis, a disease caused by the parasite Toxoplasma gondii, is one of the most common parasitic infections in the world. In the U.S. it is estimated that more than 22 percent of the population 12 years and older have ...
Medical research
5 hours ago |
not rated yet |
0
Drug found for Entamoeba histolytica parasite that is major cause of death worldwide
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against ...
Medical research
21 hours ago |
5 / 5 (1) |
0
|
When you eat matters: Study offers drug-free intervention to prevent obesity, diabetes
It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override ...
Medical research
May 17, 2012 |
5 / 5 (15) |
7
|
Pain relief through distraction -- it's not all in your head
Mental distractions make pain easier to take, and those pain-relieving effects aren't just in your head, according to a report published online on May 17 in Current Biology.
Medical research
May 17, 2012 |
5 / 5 (2) |
2
|
Growth factor in stem cells may spur recovery from multiple sclerosis
A substance in human mesenchymal stem cells that promotes growth appears to spur restoration of nerves and their function in rodent models of multiple sclerosis (MS), researchers at Case Western Reserve University School ...
New portable tool detects dengue infected mosquitoes in the field
(Medical Xpress) -- A new portable tool to detect dengue virus-infected mosquitoes will help reduce the likelihood of human infections around the world.
Novel discovery paves the way for more effective treatment of cancers
A team of scientists from the National University of Singapore's (NUS) Department of Biological Sciences and Mechanobiology Institute have discovered how a drug-led compound a compound that is undergoing preclinical ...
Tropical fruit's role as skin cancer weapon
An exciting breakthrough on the potential anti-skin cancer properties of the tropical fruit mangosteen has earned its researcher, Flinders University PhD candidate Jing Jing Wang (pictured), a seat in the ...
Use of in-hospital mortality to assess ICU performance may bias quality measurement
In-hospital mortality for ICU patients is often used as a quality measure, but discharge practices may bias results in a way that disadvantages large academic hospitals, according to a recently conducted study.
Biomarker predicts response to cancer treatment
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery ...